Pharmaceutical Company Wins Appeal for Business Expenses; Assessing Officer's Disallowance Overturned

The Tribunal allowed the appeal, holding that the expenses of Rs. 12,79,359 were incurred wholly and exclusively for business purposes and were not prohibited by law. The Tribunal concluded that the CBDT Circular and MCI Regulations do not apply to the assessee, a pharmaceutical company, and thus, the disallowance by the Assessing Officer was unjustified. The general ground of appeal was dismissed as not pressed. The appeal of the assessee was allowed, and the order was pronounced on 23/09/2021.

---

---

Issues Involved:
1. Disallowance of Business and Promotion Expenses under Section 37 of the Income Tax Act, 1961.

Issue-Wise Detailed Analysis:

Disallowance of Business and Promotion Expenses - Rs. 12,79,359

Background:
The assessee, engaged in trading and distribution of orthopedic implantable devices, filed its return for AY 2015-16, declaring a loss of Rs. 1,64,02,283. The Assessing Officer (A.O) disallowed business promotion expenses amounting to Rs. 12,79,359 under Section 37 of the Income Tax Act, 1961, citing violation of CBDT Circular No. 5/2012 and MCI Regulations, which prohibit certain expenses.

Assessee's Arguments:
1. The expenses were incurred wholly and exclusively for business purposes and should be deductible under Section 37(1) of the Act.
2. The CBDT Circular and MCI Regulations apply to medical practitioners, not pharmaceutical companies or health sector industries.
3. The assessee relied on the ITAT Mumbai decision in the case of Dy. CI-8(2) Vs. PHL Pharma P. Ltd., which supported their claim.

Revenue's Arguments:
The Revenue upheld the disallowance, arguing that the expenses violated CBDT Circular No. 5/2012 and MCI Regulations, thus making them inadmissible under the 'Explanation' to Section 37(1) of the Act.

Tribunal's Findings:
1. Nature of Expenses:
- The expenses for holding conferences and workshops were aimed at making medical professionals conversant with the products, and thus, were not gifts or freebies.
- Such expenditures were incurred in the normal course of business and should be allowable under Section 37(1).

2. Applicability of CBDT Circular and MCI Regulations:
- The Tribunal referenced the ITAT decision in Aristo Pharmaceuticals Pvt. Ltd. Vs. ACIT, which clarified that MCI Regulations apply only to medical practitioners, not pharmaceutical companies or health sector industries.
- The CBDT Circular cannot impose obligations adverse to the assessee without statutory backing.

3. Judicial Precedents:
- The Tribunal relied on the Delhi High Court decision in MAX Hospital Vs. MCI, where MCI admitted that its jurisdiction was limited to medical practitioners and did not extend to pharmaceutical companies.
- The Tribunal concluded that the MCI Regulations and CBDT Circular No. 5/2012 do not apply to the assessee, a pharmaceutical company.

Conclusion:
The Tribunal allowed the appeal, holding that:
- The expenses of Rs. 12,79,359 were incurred wholly and exclusively for business purposes and were not prohibited by law.
- The CBDT Circular and MCI Regulations do not apply to the assessee.
- The disallowance by the A.O was unjustified.

General Ground:
The general ground of appeal was dismissed as not pressed.

Final Order:
The appeal of the assessee was allowed, and the order was pronounced in the open court on 23/09/2021.

---